Internal Medicine, Hematology & Oncology · Jersey City, NJ
NPI
1124109178
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
210 Palisade Avenue
Jersey City, NJ, 07306
Phone (201) 963-2213
Groups this clinician bills Medicare through
Medicare paid, 2024
$139K
4,832 services
Medicare patients, 2024
256
Average age 76
Drug cost, 2024
$3.0M
701 prescriptions
Company payments, 2025
$2,622
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark Druck was code 99214 (office e&m - established), 750 times for 207 patients. In total Mark Druck billed 4,832 services in 18 codes, and Medicare paid $139K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 750 | 207 | $108.52 | $81K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 439 | 164 | $14.07 | $6,177 |
| 85025 Blood Count | Office | 333 | 78 | $7.29 | $2,428 |
| 96372 Injection Administration | Office | 139 | 34 | $13.08 | $1,819 |
| 99215 Office E&M - Established | Office | 103 | 52 | $160.22 | $17K |
| 99213 Office E&M - Established | Office | 64 | 50 | $73.86 | $4,727 |
| 36415 Venipuncture Blood Collection | Office | 57 | 41 | $4.81 | $274 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 47 | 18 | $0.95 | $44.51 |
| 99212 Office E&M - Established | Office | 21 | 18 | $48.00 | $1,008 |
| 99204 Office E&M - New | Office | 20 | 20 | $135.55 | $2,711 |
By year: 2022 $263K for 20,623 services; 2023 $195K for 5,324 services; 2024 $139K for 4,832 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 333 | 78 | $7.29 | $2,428 |
| 36415 Venipuncture Blood Collection | 57 | 41 | $4.81 | $274 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark Druck prescribed most often to Medicare patients was Hydroxyurea, with 49 prescriptions and refills. In total Mark Druck wrote 701 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 49 | 80 | 14 | $1,169 |
| Letrozole Generic | 46 | 90 | 14 | $994 |
| Calquence Acalabrutinib Maleate | 38 | 38 | Under 11 | $585K |
| Eliquis Apixaban | 33 | 51 | Under 11 | $29K |
| Xtandi Enzalutamide | 32 | 32 | Under 11 | $338K |
| Tamoxifen Citrate Generic | 29 | 75 | Under 11 | $1,010 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 28 | 28 | Under 11 | $214 |
| Alprazolam Generic | 25 | 25 | Under 11 | $46.65 |
| Talzenna Talazoparib Tosylate | 22 | 22 | Under 11 | $314K |
| Brukinsa Zanubrutinib | 18 | 18 | Under 11 | $210K |
| Prednisone Generic | 18 | 28 | Under 11 | $205 |
| Temazepam Generic | 16 | 16 | Under 11 | $45.41 |
| Orgovyx Relugolix | 16 | 18 | Under 11 | $48K |
| Hydrochlorothiazide Generic | 15 | 21 | Under 11 | $14.99 |
| Dexamethasone Generic | 14 | 14 | Under 11 | $103 |
Brand drugs: 291 claims; generic drugs: 410 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark Druck $2,622 ($2,622 in general payments such as food, travel and fees) from 38 companies. The largest payer was Janssen Biotech, Inc. with $324.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 19 | $324 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $261 |
| Merck Sharp & Dohme LLC MRK | 10 | $199 |
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $151 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $146 |
| Daiichi Sankyo Inc. 4568.T | 5 | $103 |
| Pfizer Inc. PFE | 6 | $93.59 |
| Astellas Pharma US Inc 4503.T | 4 | $83.61 |
| Abbvie Inc. ABBV | 4 | $76.41 |
| Gilead Sciences, Inc. GILD | 4 | $72.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.